- Home
- DGICA vs MGTX Comparison
DGICA vs MGTX Comparison
Compare DGICA & MGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DGICA | MGTX |
|---|---|---|
| Founded | 1986 | 2015 |
| Country | United States | United States |
| Employees | 851 | N/A |
| Industry | Property-Casualty Insurers | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 642.0M | 610.1M |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | DGICA | MGTX |
|---|---|---|
| Price | $17.20 | $9.32 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 7 |
| Target Price | $19.00 | ★ $22.86 |
| AVG Volume (30 Days) | 107.3K | ★ 652.1K |
| Earning Date | 04-30-2026 | 05-12-2026 |
| Dividend Yield | ★ 4.22% | N/A |
| EPS Growth | N/A | ★ 33.02 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $81,391,000.00 |
| Revenue This Year | $2.26 | $94.60 |
| Revenue Next Year | N/A | $22.27 |
| P/E Ratio | $7.82 | ★ N/A |
| Revenue Growth | N/A | ★ 144.57 |
| 52 Week Low | $16.43 | $5.02 |
| 52 Week High | $21.06 | $9.88 |
Technical Indicators
Market Signals| Indicator | DGICA | MGTX |
|---|---|---|
| Relative Strength Index (RSI) | 48.29 | 66.03 |
| Support Level | $16.52 | $7.03 |
| Resistance Level | $17.48 | $9.42 |
| Average True Range (ATR) | 0.30 | 0.58 |
| MACD | 0.08 | 0.11 |
| Stochastic Oscillator | 50.58 | 80.13 |
Price Performance
Historical ComparisonAbout DGICA Donegal Group Inc.
Donegal Group Inc is an insurance holding company that offers businesses and individuals personal and commercial lines of property and casualty insurance. The company's reportable segments are its Investment function, Personal lines of insurance, and Commercial lines of insurance. Personal lines products consist mainly of homeowners and private passenger automobile policies. The Commercial lines products of its insurance subsidiaries consist mainly of commercial automobile, commercial multi-peril, and workers' compensation policies. The group mainly operates in the United States.
About MGTX MeiraGTx Holdings plc
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.